Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is bullish on the stock heading into Phase 3 Origin results in IgAN expected ...
After hours: February 3 at 5:26:14 PM EST Loading Chart for VERA ...
After hours: February 3 at 4:02:17 PM EST Loading Chart for VRA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback